Array BioPharma aims to price public sale of its stock with greenshoe

Deal funds research and development activities and corporate purposes

By Devika Patel

Knoxville, Tenn., Nov. 8 - Array BioPharma Inc. said it plans to price a public offering of common stock. The deal will have a 30-day greenshoe.

Jefferies & Co., Inc. and J.P. Morgan Securities LLC are the joint bookrunning managers; Piper Jaffray & Co., Stifel Nicolaus Weisel and William Blair will be co-managers.

Proceeds will be used for research and development activities and general corporate purposes.

Array BioPharma is a biopharmaceutical company based in Boulder, Colo., that develops and commercializes small molecule drugs with a focus on cancer and inflammatory diseases.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.